Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group.

Poynard, T

Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. [electronic resource] - The New England journal of medicine May 1991 - 1532-8 p. digital

Publication Type: Clinical Trial; Journal Article; Meta-Analysis; Multicenter Study; Randomized Controlled Trial

0028-4793

10.1056/NEJM199105303242202 doi


Adrenergic beta-Antagonists--therapeutic use
Ascites--complications
Esophageal and Gastric Varices--complications
Female
Gastrointestinal Hemorrhage--mortality
Humans
Liver Cirrhosis--complications
Liver Cirrhosis, Alcoholic--complications
Male
Meta-Analysis as Topic
Middle Aged
Nadolol--therapeutic use
Prognosis
Propranolol--therapeutic use